Evidence map›Paper›PMID 30704119›Full record

ReviewAntibiotics (Basel, Switzerland)2019

The Use of Tethered Bilayer Lipid Membranes to Identify the Mechanisms of Antimicrobial Peptide Interactions with Lipid Bilayers.

Amani Alghalayini, Alvaro Garcia, Thomas Berry, Charles G Cranfield

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Synergistic Membrane Disruption ofBiomimetics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amani AlghalayiniSchool of Life Science, University of Technology Sydney, Ultimo, NSW 2007, Australia. Amani.Alghalayini@student.uts.edu.au.
Alvaro GarciaSchool of Life Science, University of Technology Sydney, Ultimo, NSW 2007, Australia. alvaro.garcia@uts.edu.au.
Thomas BerrySchool of Life Science, University of Technology Sydney, Ultimo, NSW 2007, Australia. Thomas.Berry@student.uts.edu.au.ORCID 0000-0002-2882-0313
Charles G CranfieldSchool of Life Science, University of Technology Sydney, Ultimo, NSW 2007, Australia. Charles.cranfield@uts.edu.au.ORCID 0000-0003-3608-5440

Funding

Australian Research Council DP160101664Australian Research Council IH150100028
6 · The paper itself

Abstract

This review identifies the ways in which tethered bilayer lipid membranes (tBLMs) can be used for the identification of the actions of antimicrobials against lipid bilayers. Much of the new research in this area has originated, or included researchers from, the southern hemisphere, Australia and New Zealand in particular. More and more, tBLMs are replacing liposome release assays, black lipid membranes and patch-clamp electrophysiological techniques because they use fewer reagents, are able to obtain results far more quickly and can provide a uniformity of responses with fewer artefacts. In this work, we describe how tBLM technology can and has been used to identify the actions of numerous antimicrobial agents.

Indexed as

antimicrobial peptideselectrical impedance spectroscopytethered bilayer lipid membranes

Identifiers

PMID30704119
PMCPMC6466558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.